Download PDF
Planta Med 2020; 86(10): 717-727
DOI: 10.1055/a-1167-4284
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Artemisiae Iwayomogii Herba Inhibits Growth, Motility, and the PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma Cells

Juyoung Kim‡
1   Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Korea
,
Kyung Hee Jung‡
1   Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Korea
,
Jin Gyu Choi‡
2   Department of Oriental Pharmaceutical Science, College of Pharmacy and Kyung Hee East-West Pharmaceutical Research Institute, Kyung Hee University, Seoul, Korea
,
Myung Sook Oh
2   Department of Oriental Pharmaceutical Science, College of Pharmacy and Kyung Hee East-West Pharmaceutical Research Institute, Kyung Hee University, Seoul, Korea
3   Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul, Korea
,
Soon-Sun Hong
1   Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Korea
› Author AffiliationsSupported by: National Research Foundation of Korea 2018R1A2A1A05077263
Supported by: National Research Foundation of Korea 2019M3E5D1A02069621
Supported by: National Research Foundation of Korea 2014009392
Further Information

Publication History

received 07 October 2019
revised 19 April 2020

accepted 24 April 2020

Publication Date:
19 May 2020 (online)

    Permissions and Reprints

Abstract

Artemisia gmelinii (Artemisia iwayomogi) has been used in traditional medicine to cure various infectious diseases such as cholecystitis, hepatitis, and jaundice. In this study, the Artemisiae Iwayomogii Herba ethanol extract was investigated for the ability to inhibit growth of hepatocellular carcinoma and its underlying mechanism involved. The antiproliferative effect of Artemisiae Iwayomogii Herba ethanol extract was evaluated using cell viability and proliferation assays. The effect of Artemisiae Iwayomogii Herba ethanol extract on apoptosis was measured using western blotting, terminal deoxynucleotidyl transferase-mediated dUTP-biotin end labeling staining, JC-1 staining, cytochrome c release, immunohistochemistry, and immunofluorescence in ex vivo mouse xenografts. Artemisiae Iwayomogii Herba ethanol extract inhibited hepatocellular carcinoma cell growth and proliferation in a dose-dependent manner. The apoptotic effect of Artemisiae Iwayomogii Herba ethanol extract was observed via increased levels of cleaved caspase-3 and cleaved PARP, as well as elevated numbers of terminal deoxynucleotidyl transferase-mediated dUTP-biotin end labeling-positive apoptotic cells. Artemisiae Iwayomogii Herba ethanol extract also decreased XIAP and Mcl-1 expression via loss of mitochondrial membrane potential. Additionally, Artemisiae Iwayomogii Herba ethanol extract inhibited hepatocellular carcinoma cell invasion and migration. In the ex vivo model, Artemisiae Iwayomogii Herba ethanol extract significantly inhibited tumor cell proliferation and increased the number of apoptotic cells with more activated cleaved caspase-3. A mechanistic study revealed that Artemisiae Iwayomogii Herba ethanol extract effectively suppressed the PI3K/AKT/mTOR signaling pathway in hepatocellular carcinoma cells. Our findings demonstrate that Artemisiae Iwayomogii Herba ethanol extract can efficiently induce apoptosis and inhibit the growth, migration, and invasion of human hepatocellular carcinoma cells, and simultaneously block PI3K/AKT/mTOR pathway. We therefore suggest Artemisiae Iwayomogii Herba ethanol extract as a novel natural agent for prevention and therapy of hepatocellular carcinoma.

Key words

Artemisiae Iwayomogii Herba - Artemisia gmelinii - Compositae - Apoptosis - hepatocellular carcinoma - PI3K
 

  • References

  • 1 Torre LA, Bray F, Sieqel RL, Ferlay J, Lortet T, Jemal J. Global cancer statistics. CA Cancer J Clin 2015; 65: 87-108
    CrossrefPubMedGoogle Scholar
  • 2 Siddharth S, Preet PS, Lewis RR, William S. Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2014; 11: 45-54
    PubMedGoogle Scholar
  • 3 Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Dig Dis Sci 2005; 50: 1807-1812
    CrossrefPubMedGoogle Scholar
  • 4 Yook CS. Coloured medicinal Plants of Korea. Seoul: Academic Press; 1989: 524
    Google Scholar
  • 5 Kim SH, Choi CH, Kim SY, Eun JS, Shin TY. Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp Biol Med 2005; 230: 82-88
    CrossrefPubMedGoogle Scholar
  • 6 Ji HJ, Yeo HK, Lee NH. Hwang JS. A carbohydrate fraction, AIP1, from Artemisia iwayomogi down-regulates FAS gene expression and suppresses apoptotic death of the thymocytes induced by 2,3,7,8-tectrachlorodibenzo-p-dioxin. Biotechnol Lett 2005; 27: 253-257
    CrossrefPubMedGoogle Scholar
  • 7 Hwang JS, Ji HJ, Koo KA. AIP1, a water-soluble fraction from Artemisia iwayomogi, suppresses thymocyte apoptosis in vitro and down-regulates the expression of FAS gene. Biol Pharm Bull 2005; 28: 921-924
    CrossrefPubMedGoogle Scholar
  • 8 Wang JH, Choi MK, Shin JW, Hwang SY, Son CG. Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model. J Ethnopharmacol 2012; 140: 179-185
    CrossrefPubMedGoogle Scholar
  • 9 Kim J. Illustrated natural Drugs Encyclopedia. Seoul: Namsadang Publishers; 1989: 249
    Google Scholar
  • 10 Park J. Korean Folk Medicine. Busan: Busan National University Publisher; 1999: 184-185
    Google Scholar
  • 11 Choi Y, Yanagawa Y, Kim S, Whang WK, Park T. Artemisia iwayomogi extract atenuates high-fat diet-induced obesity by decreasing the expression of genes associated with adipogenesis in mice. Evid Based Complement Alternat Med 2013; 2915953
    PubMedGoogle Scholar
  • 12 Park EJ, Nan JX, Kim JY. The ethanol-soluble part of a hot-water extract from Artemisia iwayomogi inhibits liver fibrosis induced by carbon tetrachloride in rats. J Pharm Pharmacol 2000; 52: 875-881
    CrossrefPubMedGoogle Scholar
  • 13 Cha JD, Jeong MR, Kim HY, Lee JC, Lee KY. MAPK activation is necessary to the apoptotic death of KB cells induced by the essential oil isolated from Artemisia iwayomogi . J Ethnopharmacol 2009; 123: 308-314
    CrossrefPubMedGoogle Scholar
  • 14 Nugroho A, Lim SC, Karki S, Choi JS, Park HJ. Simultaneous quantification and validation of new peroxynitrite scavengers from Artemisia iwayomogi. . Pharm Biol 2015; 53: 653-661
    CrossrefPubMedGoogle Scholar
  • 15 Lee YK, Hong EY, Whang WK. Inhibitory effect of chemical constituents isolated from Artemisia iwayomogi on polyol pathway and simultaneous quantification of major bioactive compounds. BioMed Res Int 2017; 2017: 7375615
    PubMedGoogle Scholar
  • 16 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674
    CrossrefPubMedGoogle Scholar
  • 17 Moeini A, Cornella H, Villanueva A. Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer 2012; 1: 83-93
    CrossrefPubMedGoogle Scholar
  • 18 Buhagiar JA, Podesta MT, Wilson AP, Micallef MJ, Ali S. The induction of apoptosis in human melanoma, breast and ovarian cancer cell lines using an essential oil extract from the conifer tetraclinis articulata. Anticancer Res 1999; 19: 5435-5443
    PubMedGoogle Scholar
  • 19 Cha JD, Jeong MR, Choi HJ. Chemical composition and antimicrobial activity of the essential oil of Artemisia lavandulaefolia . Planta Med 2005; 71: 575-577
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Dordevic S, Petrovic S, Dobric S. Antimicrobial, anti-inflammatory, anti-ulcer and antioxidant activities of Carlina acanthifolia root essential oil. J Ethnopharmacol 2007; 109: 458-463
    CrossrefPubMedGoogle Scholar
  • 21 Kordali S, Caki A, Mavi A, Kilic H, Yildirim A. Screening of chemical composition and antifungal and antioxidant activities of the essential oils from three Turkish Artemisia species. J Agric Food Chem 2005; 53: 1408-1416
    CrossrefPubMedGoogle Scholar
  • 22 Xiong F, Guan YS. Cautiously using natural medicine to treat liver problems. World J Gastroenterol 2017; 23: 3388-3395
    CrossrefPubMedGoogle Scholar
  • 23 Lee JK, Kim JH, Shin HK. Therapeutic effects of the oriental herbal medicine sho-saiko-to on liver cirrhosis and carcinoma. Hepatol Res 2011; 41: 825-837
    CrossrefPubMedGoogle Scholar
  • 24 Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002; 108: 153-164
    CrossrefPubMedGoogle Scholar
  • 25 Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000; 102: 1-4
    CrossrefPubMedGoogle Scholar
  • 26 Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776
    CrossrefPubMedGoogle Scholar
  • 27 Pistritto G, Trisciuoglio D, Ceci C, Garufi A, DʼOrazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging 2016; 8: 603-619
    Google Scholar
  • 28 Shimizu S. Development of anti-cancer drugs mediated by apoptosis and autophagy. Nihon Rinsho 2015; 73: 1302-1307
    PubMedGoogle Scholar
  • 29 Qiu J, Luo M, Wang J. Isoalantolactone protects against Staphylococcus aureus pneumonia. FEMS Microbiol Lett 2011; 324: 147-155
    CrossrefPubMedGoogle Scholar
  • 30 Rasul A, Yu B, Khan M. Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/AKT signaling pathways. Int J Oncol 2012; 40: 1153-1161
    CrossrefPubMedGoogle Scholar
  • 31 Liu XL, Zhang L, Fu XL, Chen K, Qian BC. Effect of scopoletin on PC3 cell proliferation and apoptosis. Acta Pharmacol Sin 2011; 22: 929-933
    PubMedGoogle Scholar
  • 32 Yang JS, Liu CW, Ma YS. Chlorogenic acid induces apoptotic cell death in U937 leukemia cells through caspase- and mitochondria-dependent pathways. In Vivo 2012; 26: 971-978
    PubMedGoogle Scholar
  • 33 Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006; 441: 424-430
    PubMedGoogle Scholar
  • 34 Zhang H, Wang Q, Liu J, Cao H. Inhibition of the PI3K/AKT signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma. Oncol Lett 2018; 15: 9377-9384
    PubMedGoogle Scholar
  • 35 Crane C, Panner A, Pieper RO, Arbise J, Parsa AT. Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting t cell function. J Immunother 2009; 32: 585-592
    CrossrefPubMedGoogle Scholar
  • 36 Rasul A, Khan M, Yu B. Isoalantolactone, a sesquiterpene lactone, induces apoptosis in SGC-7901 cells via mitochondrial and phosphatidylinositol 3-kinase/AKT signaling pathways. Arch Pharm Res 2013; 36: 1262-1269
    CrossrefPubMedGoogle Scholar